Teva Pharma (TEVA) Price Target Raised to $64 at Deutsche Bank
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rises as oil slide offers respite after Fed rate hike
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Paradium AI (PAAI) Halted, News Pending
Teva Pharma (TEVA) Tops Q3 EPS by 9c
October 30, 2014 7:04 AM EDTTeva Pharma (NYSE: TEVA) reported Q3 EPS of $1.32, $0.09 better than the analyst estimate of $1.23. Revenue for the quarter came in at $5.06 billion versus the consensus estimate of $5.09 billion.
For earnings history and earnings-related data on Teva Pharma (TEVA) click here.
... More